According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2022 the company made an earning of -$0.12 B a decrease over its 2021 earnings that were of -$93.15 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.17 B | 44.27% |
2022 | -$0.12 B | 19.64% |
2021 | -$93.15 M | 1732.84% |
2020 | -$5.09 M | -86.83% |
2019 | -$38.59 M | -65.92% |
2018 | -$0.12 B | -222.16% |
2017 | $92.66 M | -1053.49% |
2016 | -$9.72 M | -112.59% |
2015 | $77.19 M | -185.94% |
2014 | -$89.83 M | 66.04% |
2013 | -$54.1 M | 582.16% |
2012 | -$7.93 M | -7.6% |
2011 | -$8.59 M | -2.1% |
2010 | -$8.77 M | 32.52% |
2009 | -$6.62 M | -64.36% |
2008 | -$18.57 M | -52.93% |
2007 | -$39.44 M | 5.66% |
2006 | -$37.32 M | 17.86% |
2005 | -$31.67 M | -375.09% |
2004 | $11.51 M | -406.44% |
2003 | -$3.76 M | -145.2% |
2002 | $8.3 M | -363.36% |
2001 | -$3.16 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 14.64% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -88.21% | ๐บ๐ธ USA |